Trxade Health Inc (NASDAQ: MEDS) Forecasts And Short-Term Estimates

In the latest trading session, 1.38 million Trxade Health Inc (NASDAQ:MEDS) shares changed hands as the company’s beta touched 2.14. With the company’s most recent per share price at $8.46 changing hands around $1.87 or 28.28% at last look, the market valuation stands at $11.93M. MEDS’s current price is a discount, trading about -251.65% off its 52-week high of $29.75. The share price had its 52-week low at $2.46, which suggests the last value was 70.92% up since then. When we look at Trxade Health Inc’s average trading volume, we note the 3-month average coming to 35.96K.

Trxade Health Inc (NASDAQ:MEDS) trade information

Instantly MEDS is in green as seen in intraday trades today. With action 42.30%, the performance over the past five days has been green. The jump to weekly highs of 10.90 added 28.28% to the stock’s daily price. The company’s shares are showing year-to-date upside of 143.86%, with the 5-day performance at 42.30% in the green. However, in the 30-day time frame, Trxade Health Inc (NASDAQ:MEDS) is 50.53% up.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Trxade Health Inc (MEDS) estimates and forecasts

Year-over-year growth is forecast to reach -27.70% down from the last financial year.

Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 2.28M. 1 analysts are of the opinion that Trxade Health Inc’s revenue for the current quarter will be 2.35M. The company’s revenue for the corresponding quarters a year ago was 2.4M and 2.53M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -5.00%. The estimates for the next quarter sales put growth at -7.00%.